Biotech · Private company

TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)

Track this companyFree. Adds TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics) to your Dealase workspace and tells you when its record changes.

Clinical trials33 recruiting or active

Pipeline programs14From trials and the company's site

Disclosed deals0None found yet

Cash runwayNot availablePrivate: no SEC financials

Pipeline14

BBO-10203Phase 1 · Solid Tumor, AdultClinicalTrials.gov · fetched Nov 12, 2026
BBO-10203Phase 1 · Non-small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
BBO-11818Phase 1 · Non-Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
BBO-8520Phase 1 · Non-small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
BevacizumabPhase 1 · Solid Tumor, AdultClinicalTrials.gov · fetched Nov 12, 2026
CetuximabPhase 1 · Non-Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
FOLFOXPhase 1 · Solid Tumor, AdultClinicalTrials.gov · fetched Nov 12, 2026
FulvestrantPhase 1 · Solid Tumor, AdultClinicalTrials.gov · fetched Nov 12, 2026
mFOLFOX6Phase 1 · Non-Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
PembrolizumabPhase 1 · Non-small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
PemetrexedPhase 1 · Non-Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
Platinum chemotherapy (cisplatin or carboplatin)Phase 1 · Non-Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
RibociclibPhase 1 · Solid Tumor, AdultClinicalTrials.gov · fetched Nov 12, 2026
TrastuzumabPhase 1 · Solid Tumor, AdultClinicalTrials.gov · fetched Nov 12, 2026

Clinical trials3

BBO-11818 in Adult Subjects With KRAS Mutant CancerPHASE1 · RECRUITING · started Mar 31, 2025ClinicalTrials.gov NCT06917079 · fetched Nov 12, 2026
Open-Label Study of BBO-10203 in Subjects With Advanced Solid TumorsPHASE1 · RECRUITING · started Oct 29, 2024ClinicalTrials.gov NCT06625775 · fetched Nov 12, 2026
Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung CancerPHASE1 · RECRUITING · started May 22, 2024ClinicalTrials.gov NCT06343402 · fetched Nov 12, 2026